Healthcare / Drug Discovery

Synthetic biology (SB) is an emerging discipline, which is slowly reorienting the field of drug discovery. It  focuses on re-engineering bacteria and yeast for use as microscopic drug factories, and in the manipulation of mammalian gene expression. Synthetic biology designs biological devices (synthetic cells or cell-free system) to trigger a biological response with respect to input controlled signal. In Drug Discovery, such devices would be used to activate gene expression of biosynthetic units to explore  natural products -like chemical space. Genome editing tools give the possibility of following through reporter genes the action of a particular output signal, which is very useful to validate drug target or disease models as well as merging constraints from both Drug Discovery and drug production. 
  • Synthetic Cells
  • Peptide Nanoparticle-Based Vaccines
  • Liposome-Based Synthetic Vaccines
  • Reverse Vaccines against Microbial Pathogens

Related Conference of Healthcare / Drug Discovery

February 24-25, 2020

24th Global Congress on Biotechnology

London, UK
June 28-30 2020

Stroke Summit 2020

July 15-16, 2020

12th World Congress and Expo on Stem Cell Research

Prague, Czech Republic
September 23-24, 2020

24th European Biotechnology Congress

Berlin, Germany
October 19-20, 2020

7th Asia Pacific Geriatrics and Gerontology Congress

Tokyo, Japan
October 23-24, 2020

2nd International Conference on Biomarkers and Cancer Targets

Cape Town, South Africa
November 23-24, 2020

International Conference on Toxicogenomics

Bali, Indonesia
December 07- 08, 2020

2nd World Congress on Cell and Structural Biology

Sydney, Australia
December 14-15, 2020

New frontiers in Genetics Research & Advanced Techniques

San Antonio, USA

Healthcare / Drug Discovery Conference Speakers

Recommended Sessions

Related Journals

Are you interested in